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Out of hospital cardiac arrest is a major cause of mortality with an estimated yearly 
incidence of 350,000 in the United States alone.  Cardiopulmonary resuscitation (CPR) is a 
treatment for cardiac arrest involving chest compressions and rescues breaths that can save lives 
but is limited by the fact that it currently treats all patients in a 'one size fits all' approach.  This 
work describes an adaptive approach to chest compressions controlled by a mechanical device that 
receives biosignals from the patient it treats.  The device is capable of adjusting its chest 
compression parameters such as rate and depth in response to the biosignals it receives.  We 
focused on integrating the quantitative electrocardiogram (QECG) of the ventricular fibrillation 
signal, a biosignal shown to respond to increased perfusion of the myocardium during CPR, into 
a chest compression algorithm controlled by the adaptive chest compression device.  QECG is 
readily available for cardiac arrest patients since ECG analysis is standard of care in cardiac arrest.  
In our first aim we developed the adaptive chest compression device and tested it in animal 
feasibility studies which demonstrated that it responded appropriately to the biosignals it received.  
Next, in a computational model of adaptive chest compressions, adjustments in chest compression 
depth yielded the largest increase in cardiac output in patients with simulated variable physiology. 
In follow-up animal studies, select QECG measures responded to changes in chest compression 
parameters which demonstrated the initial feasibility of QECG measures as a potential biosignal 
in this model.  We found that the QECG measures of median slope, centroid frequency, and log of 
the absolute correlation responded to changes in chest compression rate in the early phase of chest 
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compressions.  We found that in late phases of chest compressions the QECG measure median 
slope responded to chest compression rate changes and the QECG measure AMSA responded to 
chest compression duty cycle changes.  Our second aim sought to retrospectively translate the 
findings in the first aim animal studies to human clinical data in the continuous chest compression 
trial of the Resuscitation Outcomes Consortium (ROC).  The clinical trial provided us with ECG 
and compression data in covering thousands of cardiac arrest events. All QECG metrics in the 
clinical data set was predictive of shock outcome and chest compression rate along with chest 
compression bout duration were predictive of survival.  However, when controlled for the 
presenting first rhythm status and demographic variables, only chest compression bout duration 
was predictive of survival.  In addition to the predictive value of chest compression parameters 
and QECG measures, associations were found between varying chest compression parameters 
averaged across bouts of compressions with change in QECG values (dQECG) in the clinical data.  
Chest compression rate was found to be predictive of the dQECG metric median slope (dMS) and 
the dQECG metric (dAMSA).  Dosed compression rate was found to be predictive of the dQECG 
metric dMS as well.  dCF responded to changes in chest compression duty cycle. These findings 
provide a foundation for delivering adaptive chest compressions with the potential of improving 
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1.0  INTRODUCTION 
1.1 CARDIAC ARREST 
Out-of-hospital cardiac arrest (OHCA) is a leading cause of mortality in the industrialized 
world[1].  OHCA is characterized as an abrupt cessation of mechanical activity of the heart leading 
to the loss of blood perfusion to vital organs which sustain life.  OHCA, when left untreated, leads 
to sudden cardiac death (SCD).  Successful treatment of OHCA necessarily involves 
cardiopulmonary resuscitation (CPR).   
 
CPR combines both rescue breaths to provide oxygenation and ventilation and chest 
compressions that function to circulate blood and perfuse vital organs.  CPR is performed with the 
primary purpose of circulating blood until electrical defibrillation is available.  To an extent, chest 
compressions ‘prime’ the heart with perfusion so that it will be more responsive to a defibrillation 
attempt. Successful defibrillation terminates cardiac arrest and can be performed in both the out-
of-hospital and in-hospital settings. 
1.1.1 Cardiac Arrest Etiology 
OHCA has a variety of etiologies.  These etiologies can be categorized into medical or non- 
medical. A majority of OHCA cases have a presumed cardiac (medical) etiology (55-78%)[2-5]. 
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Medical etiologies of OHCA are most often attributed to coronary artery disease[6]. OHCA is 
initiated from life threatening arrhythmias such as ventricular fibrillation (VF), asystole, (AS), 
ventricular tachycardia (VT), or pulseless electrical activity (PEA).   
  
Non-medical causes of OHCA include trauma, obstructive pulmonary disease, drug abuse, 
or unknown causes. One study that looked at 1360 OHCA found that 25% were determined to be 
initiated by a non-cardiac etiology[4]. 
1.1.2 Incidence and Outcomes 
Surviving a cardiac arrest is difficult and the approach to treatment is clinically 
challenging.  Despite aggressive efforts to both raise awareness of OHCA and teach CPR to the 
public, survival rates from OHCA are dismal[1]. The latest statistics from the American Heart 
Association (AHA) report that survival to hospital discharge from OHCA with any first recorded 
rhythm was 10.6% for all ages.  Factors that improve the likelihood of survival include younger 
age, whether the cardiac arrest was witnessed by a bystander, whether bystander CPR was 
performed, whether the cardiac arrest was in public, and whether the first rhythm observed in the 
cardiac arrest was a rhythm capable of being defibrillated. Survival odds also appear to increase 
when a non-shockable rhythm is converted to a shockable rhythm[7]. 
1.1.3 Stages of Cardiac Arrest 
Drastic physiologic changes occur within the body during the course of cardiac arrest. 
These changes can be described as a time sensitive model, split into three phases that include 
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electrical, circulatory, and metabolic[8]. The three stage model, has developed into a treatment 
paradigm, where each stage would be more responsive to select resuscitation treatments.  The 
model established an approach to cardiac arrest where select interventions that are timed to 
coordinate with changing physiology would provide the most benefit to the patient.  
In the electrical phase, commonly defined as the first four minutes of cardiac arrest, 
defibrillation is viewed as the most critical treatment in reversing lethal arrhythmias[8].  Chest 
compressions and rescue breaths are necessary during this first phase, however electrical 
defibrillation is paramount in reversing arrhythmia as there is still adequate energy stores in the 
myocardium to facilitate successful defibrillation.  The importance of early defibrillation is 
realized in a study that showed prompt defibrillation in OHCA yielded a hospital discharge rate of 
29.3% when compared to patients in whom defibrillation was delayed by 2 minutes or more from 
onset of VF.  The delayed comparison group had a hospital discharge rate of 22.2% [9]. 
In the circulatory phase of cardiac arrest, the myocardium has been further starved of 
oxygen, and its optimal viability for cardioversion.  This period is commonly defined as the 4th to 
10th minute after onset of cardiac arrest[8].  During the circulatory phase of cardiac arrest, chest 
compressions remain of paramount importance to keep the myocardium perfused so that the 
window for successful defibrillation remains intact. 
In the metabolic phase of cardiac arrest, the myocardium has been starved of oxygen for 
longer than 10 minutes[8].  Continued perfusion generated through chest compressions is now 
required to prime the heart after the optimal window for defibrillation has passed.  Chest 
compressions remain vital during the metabolic phase, but often other treatment options are 
required at this point such as drug delivery and extracorporeal membrane oxygenation[10]. 
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1.2 CARDIOPULMONARY RESUSCITATION  
Cardiopulmonary Resuscitation (CPR), first described in detail in the 1960s, is a proven 
treatment for OHCA and has shown strong evidence to improve survival odds when performed 
correctly and with limited delay[11-14].  Chest compressions during CPR are delivered through a 
rhythmic, downward force and can be given to patients manually or with mechanical devices.  This 
motion encompasses various parameters that define CPR including rate of compression, depth of 
compression, compression duty cycle, and CPR fraction.    
Chest compressions are delivered as an applied force to the sternum of the patient.  This 
cyclic movement can be generalized to a kinematic relationship between the downward force of 
the chest compression, whether delivered by a provider’s hands or a medical device, and the 
volumetric rate of blood flow leaving the heart.  Efforts have been made in the past by other 
research groups and organizations to standardize the reporting of CPR metrics[15].  Diligence has 
been made in the work described in this dissertation to adhere to these standards. 
 
1.2.1 CPR Mechanism 
Chest compressions, when defined by variables such as rate, depth, and duty cycle have a 
tendency to be highly variable when delivered by medical providers and bystanders[16, 17]. Large 
clinical trials have measured chest compression parameters and subsequently paired them with 
clinical outcomes [18, 19].  Common chest compression parameters include chest compression 
depth, chest compression rate, and chest compression duty cycle.  These three parameters are 
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shown and defined visually in Figure 1.  In Figure 1 the sinusoidal waveform representative of 
continuous chest compressions is quantified using a graphical representation. 
There are two primary theories that explain the mechanism of CPR.  The two mechanisms 
include the cardiac pump model and the thoracic pressure model.  In the cardiac pump model chest 
compressions during the downward motion squeeze the heart between the sternum and spinal 
column causing the ejection of blood [20].  This applied pressure is the contributing force for 
forward movement of blood. 
In the thoracic pressure model, a rise in the intrathoracic pressure generated by the ‘release’ 
of a chest compression creates a pressure differential necessary for blood to fill the heart.  In the 
thoracic model intrathoracic pressure is transmitted unequally to the peripheral arterial and venous 
tree.  This generates what is described as a peripheral arteriovenous pressure gradient that is the 
Figure 1: Chest compression parameters defined on sample waveform 
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pressure difference responsible for the generation of blood flow[21].  This description of the CPR 
mechanism has been further confirmed in animal studies that have observed echocardiography and 
pressure gradients in animal and human studies[22, 23]. 
A further study by Paradis et al., determined that the intrathoracic pressure and cardiac 
pump models are not mutually exclusive[24].  An even more recent study has shown that 
hemodynamics during CPR may not be governed by a specific model, but a complex interaction 
of forward and backward flow within the thoracic space[25]. 
Many factors in the delivery or timing of CPR may affect its potential to produce positive 
outcomes for patients such as chest compression depth, chest compression rate, and chest 
compression duty cycle. 
1.2.2 Chest Compression Depth 
The depth of the chest compressions contributes as a factor to the cardiac pump model of 
CPR.  Depth has long been a target parameter to optimize during CPR, with a targeted depth of 2 
inches for adults set by the American heart association (AHA) as an evidence-based guideline[1]. 
Chest compression depth in the out-of-hospital setting when studied in large clinical trials 
including the Resuscitation Outcomes Consortium (ROC) have been found to be variable.  In this 
trial, increasing chest compression depth was directly correlated with resuscitation outcomes when 
adjusting for case and process characteristics[26].  In other studies deeper chest compressions were 
associated with an increased probability of survival and favorable functional outcome[18, 27].   
The survival dependence of chest compression depth at a population level from analyses 
conducted by Stiel et al. is shown in Figure 2 above letter A.  The findings summarized in this 
figure demonstrate that the probability of survival from cardiac arrest increases linearly for mid-
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range chest compression depths studied in the trial.  The linear increase in benefit however was 
not seen for chest compression depths at the high and low end of chest compression depths 
observed in this study.   
The effect of insufficient compression depth also has a deleterious effect on defibrillation 
success.  In one study a higher mean compression depth during the 30 seconds immediately 





Figure 2: Survival Dependence on chest compression depth and rate in OHCA 
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1.2.3 Chest Compression Rate 
Chest compression rate plays an important role in generating blood perfusion during CPR 
and has been studied extensively in the delivery of CPR.   Too fast of a rate may not allow for 
adequate venous return of blood to the heart during CPR if there is reduced filling time caused by 
a fast chest compression rate.  Moreover a faster rate is associated with a reduction in sufficient 
depth[29].  If the compression rate is too slow, cardiac output is compromised as less volume of 
blood is ejected from the heart over time. 
When assessing the chest compression rates in manikins one study found that a chest 
compression rate between 100 and 120 compressions per minute did not compromise other chest 
compression parameters such as chest compression depth and chest compression duty cycle[30].  
Another group found that chest compression rate was associated with return of spontaneous 
circulation (ROSC) but not survival to hospital discharge[31].  A further study found that after 
adjustment for chest compression fraction and chest compression depth, chest compression rates 
between 100 and 120 compressions per minute were associated with the greatest likelihood for 
survival to hospital discharge[19].  The survival dependence of chest compression rate at a 
population level from Idris et al. is shown in Figure 2 above letter B.  This figure summarizes the 
findings in the study and demonstrates that there is a strong negative    Higher chest compression 
rates have also been found to increase the likelihood for ROSC[32]. 
1.2.4 Chest Compression Duty Cycle 
Duty cycle plays an important role in the perfusion and movement of blood during CPR.  
Duty cycle of a chest compression is defined as the proportion of the time spent compressing the 
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chest in one chest compression cycle (start of one compression to start of next compression).  Some 
studies suggest that by increasing duty cycle or increasing the duration of the chest compression 
downstroke, more effective chest compressions would be generated because of the increased 
refilling time of the thorax[33].  This reasoning speaks to the thoracic mechanism of generating 
filling pressures as well as enhancing the downstroke ejection phase explained by the cardiac pump 
mechanism. 
Although some initial studies using animal data found that a 30% duty cycle optimized 
blood flow, AHA guidelines recommend a 50% duty cycle for OHCA CPR treatment, largely 
based on animal data[1, 33].  This guideline has been found to be largely unmet according to a 
CPR analysis that found the median duty cycle in a sample of 164 patients to be 38.8%[34]. 
Duty cycle has also been studied in the context of incomplete chest wall decompression.  
This is a significant area of research study as the phenomenon of incomplete chest wall 
decompression is often a result of ‘leaning’ by the CPR provider and/or fatigue.  Leaning during a 
compression occurs when the provider fails to completely remove compressive force after the 
upstroke of compression. As the provider fatigues throughout the duration of CPR leaning 
becomes more prevalent resulting in incomplete chest recoil and CPR quality is compromised[35]. 
1.2.5 Chest Compression Fraction 
Chest compression fraction (CCF) refers to the fraction of time during a cardiac arrest that 
chest compressions are given.  In an observational cohort of the ROC trial, one study found that 
an increase in chest compression fraction was independently predictive of survival. This effect 
however was only studied in VF/VT as the presenting rhythm subset[36].  In a further analysis of 
non-VF patients the survival effect was not as strong.[37]  
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The effect of pauses in chest compressions on perfusion pressure can be visualized in 
Figure 3.  Any brief pause in perfusion will decrease blood perfusion to the brain, worsen ischemia, 
and result in a period of inadequate perfusion during the time chest compressions have begun to 
resume. 
 
Figure 3: Pauses in chest compression affects perfusion pressure 
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1.3 CARDIAC ARREST OUTCOMES AND BIOSIGNALS 
1.3.1 Cardiac Arrest Outcomes 
Outcomes from cardiac arrest range from short term, return of spontaneous circulation 
(ROSC) and changes in blood pressure, to long term, survival to hospital discharge and 
neurological outcome at hospital discharge.  Long term survival follow-up has been used as well 
ranging from days to years. 
ROSC is viewed as a positive outcome of CPR.  Successful achievement of ROSC in the 
cardiac arrest patient, as well as animal models of cardiac arrest is indicative of a beneficial 
response to CPR.  Evidence of ROSC, especially when reviewing cardiac arrest signal data such 
as the electrocardiogram (ECG) retrospectively, is difficult to definitively confirm.  Higher 
coronary perfusion pressure (CPP) and 'dose' of elevated CPP over the course of cardiac arrest, are 
predictive of ROSC[38]. 
The definition of ROSC by most standards not only requires ECG indicative of a beating 
heart, but requires a palpable pulse.  The presence of pulseless electrical activity (PEA), a lethal 
arrhythmia that sometimes resembles healthy ECG, may confound the ability to confirm ROSC. 
This is due to the fact that without physical palpation of an artery or connection to a blood pressure 
monitor, a PEA rhythm may appear to be pulsatile when it is actually in fact pulseless.  End-tidal 
carbon dioxide levels (EtCO2) measured through the endotracheal tube is used in distinguishing 
true PEA from a pulsatile rhythm. 
Survival is the most desirable outcome measurement or cardiac arrest however even after 
surviving a cardiac arrest, quality of life is often accompanied with neurologic injury[12].  Survival 
to hospital discharge even when taken as a positive outcome may not capture the overall medical 
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condition of the patient.  Detailed assessments of the neurologic status of the patient post-hospital 
discharge such as the Modified Rankin Scale (MRS) further help elucidate treatment effects and 
outcomes of OHCA[12].  
1.3.2 Biosignals During Cardiac Arrest 
Unlike short or long term outcomes, biosignals provide real-time feedback of the effects of 
CPR.  Biosignals generated from the patient during cardiac arrest are direct responses to the CPR 
being delivered.  Biosignals that have shown evidence to be feasible in monitoring perfusion in 
cardiac arrest include end-tidal carbon dioxide levels (EtCO2), pulse oximetry, and invasive 
pressure measurements[38-41].  Although this feedback is not immediate, it is most often in the 
time-scale of seconds, allowing any resuscitation intervention to be titrated to change in biosignals. 
Biosignals in the context of cardiac arrest are physiologic responses that the body generates 
in response to CPR.  Translating the hemodynamics that are generated from the applied force in a 
chest compression into discernable biosignals that measure CPR effectiveness, is difficult[25].  
Some biosignals characterize the ECG during cardiac arrest[42].  These metrics are called 
quantitative electrocardiogram signals (QECG). 
1.3.3 Electrocardiogram in Cardiac Arrest 
The ECG is a measure of the electrical activity of the heart.  The ECG is recorded through 
electrodes and represents the superposition of the sum of electrical fields across the myocardium.  
In healthy individuals, the ECG is driven by pacemaker cells in the sinoatrial node of the heart.  
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Cardiac cells then experience a progression of depolarization events that trigger the atria and 
ventricles to contract.   
In cardiac arrest, the ECG waveform is generally categorized into four distinct rhythms, 
ventricular fibrillation (VF), ventricular tachycardia (VT), asystole (AS), or pulseless electrical 
activity.  VF and VT have the potential to be defibrillated, while AS and PEA do not.  A 
prospective observational trial of more than 400 hospitals that involved over 50,000 patients from 
1999 to 2005 found that that the shockable rhythms of VF and VT had a prevalence of 24% 
compared to 37% PEA and 39% AS[14].  Similar findings were observed in other studies as well 
[7, 43]. As would be expected, studies have shown that having a shockable rhythm at any point 
during OHCA is favorable for patient outcomes[7].   
1.3.4 QECG Metrics as a Biosignal 
The VF waveform has morphologic characteristics that can be quantified.  These 
quantifiable characteristics make up QECG biosignals mentioned in the previous section.  QECG 
involves components of the frequency and amplitude distribution of VF, as well as non-linear 
characterizations.  QECG metrics are well described in the literature for their ability to predict 
shock success[44].  Amplitude methods, when compared to frequency methods, have a limitation 
in their ability to drive resuscitation in that they are more susceptible to movement artifact, 
recording devices, body habitus, and electrode placement[44]. 
VF waveforms exhibit predictable changes over the course of cardiac arrest.  The signal 
characteristics of the VF and VT waveform are a reflection of the energy status of the myocardium, 
specifically the presence of high energy phosphates such as ATP[45].  During ischemia of the 
myocardium in untreated cardiac arrest, the organization of the VF waveform deteriorates from 
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course, low frequency characteristics, to fine, high frequency characteristics.  This change in VF 
waveform from ‘course to fine’ in untreated cardiac arrest reflects the ion imbalance across the 
cell membrane.   These changes can be seen in Figure 4, taken from a review paper by Callaway 
and Menegazzi, and demonstrates the time sensitive response of QECG values [44].  In Figure 4, 





Figure 4: QECG response to untreated cardiac arrest 
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Research has shown that this deterioration could possibly be due to energy failure, acidosis 
local hyperkalemia, progressive development of chaotic turbulence, conduction blocks, and 
changes in restitution potential during ischemia[46-49]. 
QECG metrics were first used in the application of shock prediction.  Multiple studies have 
confirmed that quantifying the components of the VF waveform prior to a defibrillation attempt 
can predict the likelihood of a successful defibrillation. Early studies examined amplitude based 
QECG metrics, however amplitude based metrics had been found to be susceptible to electrode 
placement and were initially determined to be untrustworthy in evaluating the status of the 
myocardium[44].  The focus of VF waveform analysis was then placed on frequency component 
analysis. 
Other studies have found that QECG metrics are better predictors of successful 
defibrillation in a prolonged model of cardiac arrest when compared to shorter duration arrests 
giving credence that shock prediction by QECG is a dynamic process[50].  In shock resistant VF, 
AMSA and ECG slope are highly predictive of shock success[51]. 
One study found that the amplitude QECG measures were the best at shock success 
prediction, outperforming frequency and nonlinear based QECG metrics[52].  This was a study 
that observed 3,828 defibrillations from 1,617 patients and found that combining multiple metrics 
together, did not improve the detection accuracy for successful defibrillation.  
1.3.5 Common QECG Metrics 
Common QECG metrics characterize both the frequency components and the amplitude 
components of the VF waveform.  Additional metrics incorporate non-linear components of the 
VF waveform.  The QECG metrics used in this dissertation include amplitude spectrum area 
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(AMSA), median slope (MS), centroid frequency (CF), log of the absolute correlation (LAC), and 
detrended fluctuation analysis (DFA).  
1.3.5.1 AMSA 
Amplitude spectrum area is a metric that quantifies the frequency components of the VF 
waveform.  AMSA is calculated as the sum of contributing frequencies weighted by the absolute 
values of the Fourier transform of the signal.  Multiple studies have confirmed its ability to predict 
the outcome of defibrillation in the cardiac arrest patient[53-55].  The equation used for AMSA is 
shown in Figure 5. 
 
1.3.5.2 Median Slope 
Median slope is an amplitude measure of the VF waveform, taken as the median of 
successive ECG voltage values, and has been used to predict shock success.  MS is commonly 
included with other amplitude measures such as mean slope.    The equation for median slope is 
shown in Figure 6. 
Figure 5: Equation for AMSA 
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1.3.5.3 Centroid Frequency 
CF gives insight into the frequency composition of VF and is the frequency coordinate of 
the center of the spectral mass.  CF is calculated as the mean of all contributing frequencies of VF 
weighted by the power at each frequency[42, 56].  The equation for centroid frequency is shown 
in Figure 7. 
 
Figure 6: Equation for median slope 
Figure 7: Equation for centroid frequency 
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1.3.5.4 Logarithm of Absolute Correlation 
Logarithm of the Absolute Correlation (LAC) is described as a measurement of the 
‘roughness’ of the VF waveform and seeks to quantify the periodicity and self-similarity of VF.  
It has been used in the study of shock prediction in OHCA as it less affected by lower sampling 
rates common in defibrillator monitors when compared to more complex non-parametric QECG 
measures such as the scaling exponent[57].  The equation for LAC is shown in Figure 8. 
 
1.3.5.5 Detrended Fluctuation Analysis 
Non-linear measures of QECG include the metric DFA.  DFA is a measure of randomness 
of the VF signal and has been shown in studies to predict defibrillation success[58].  One limitation 
of computational intensive calculations such as DFA is that they are sensitive to filtering and noise 
common in patient monitors in the out-of-hospital setting.  The equation for DFA is shown in 
Figure 9. 
Figure 8: Equation for LAC 
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1.3.5.6  Models with Multiple QECG Metrics 
It has often been thought that combining multiple frequency based metrics may produce a 
stronger predictive value for defibrillation success, and that the nuance gained from a single metric, 
such as AMSA could be broadened with the addition of other frequency metrics.  Neurater et al. 
attempted to improve the predictive capability through neural networks composed of single 
predictive features and were unable to increase sensitivity or specificity[59].  This study however 
was conducted on a sample of only 197 recordings, much smaller than the work presented here.  
Multiple QECG metrics and their ability to predict shock outcome was also demonstrated in other 
studies of defibrillation outcomes[52, 60]. 
Figure 9: Equation for DFA 
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1.4 QECG RESPONSE TO CPR 
QECG metrics have the potential to not only play a role in the timing of shock attempts, 
but also play a role in the guidance of chest compressions.  Chest compressions have a direct effect 
on myocardial perfusion, which consequently drives QECG changes and shock viability.  In an 
animal study, Salcido and colleagues demonstrated that QECG is responsive to deterioration of 
myocardial perfusion during untreated VF as well as reperfusion during cardiopulmonary bypass.  
During untreated VF, the QECG values change in a direction that is indicative of poor perfusion 
of the myocardium; these values recover once perfusion is reestablished[10, 61].   
This phenomenon is observed in Figure 10 from a study performed by Salcido and 
colleagues.[10]   In this study cardiac arrest was induced at time =0 and left untreated for either 
15, 10, 25, or 30 minutes.  At the end of untreated ischemia reperfusion was provided to the animal 
through the use of extracorporeal membrane oxygenation (ECMO) to simulate optimal delivery of 
perfusion through chest compressions.  When ECMO was initiated the median slope QECG metric 
recovered to near baseline levels in the 15 and 20 minute groups but struggled to recover in the 
longer ischemia groups of 25 and 30 minutes.  These data demonstrate that recovery of QECG 
metrics is not only based on quality reperfusion but also the time duration of ischemia before 
reperfusion is initiated. 
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Invasive pressure measurements such as coronary perfusion pressure and mean arterial 
pressure have been the most desirable metric for measuring the effectiveness of chest 
compressions.  However, these invasive metrics are unavailable in the out-of-hospital setting.  In 
contrast, all cardiac arrest patients are instrumented with ECG leads per standard of care for cardiac 
arrest.  This noninvasive approach of quantifying the ECG signal is more feasible than an invasive 
pressure measurement requiring extensive training, a sterile environment, and time to instrument 
the patient for measurement.  The advantage of using QECG metrics for not only defibrillation 
Figure 10: QECG response to ischemia and perfusion 
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guidance, but chest compression feedback is that chest compression feedback based on QECG 
could increase survival odds in addition to successful defibrillation odds.  
A study by Indik et al. provides evidence that AMSA and slope of the ECG were predictive 
of shock success in a cardiac arrest model of prolonged VF[50].  This study provides further 
evidence that timing, of both chest compressions and defibrillation, is of importance in the delivery 
of chest compressions. 
There are two obvious limitations to the QECG approach to drive defibrillation decisions 
and monitor resuscitation efforts.  To quantify ECG accurately, the signal collection process needs 
to be artifact-free.  Chest compressions that are part of CPR and likely ongoing during QECG 
analysis produce artifact.  Movement of the patient by medical providers may also cause artifact 
to occur in the ECG signal.  This artifact can be mitigated through certain techniques, however it 
is still an issue for real-time QECG analysis[62-64].  The other limitation is that the ECG rhythm 
must be VF for QECG analysis.  VF occurs in cardiac arrest in only about a fourth of all cases. 
The work described in this dissertation seeks to further link the relationships between the 
way chest compressions are delivered to the QECG biosignals that are generated from treatment. 
1.5 GOAL DIRECTED CPR 
Cardiac arrest patients have varying chest anatomy, body mass index (BMI), and 
underlying etiology.  A tailored therapeutic response to the individual patient would therefore be  
beneficial to the OHCA patient.  CPR that changes and adapts to meet certain physiologic goals, 
have long been theorized to improve organ perfusion and subsequently improve outcomes.  The 
adoption of mechanical chest compression devices for OHCA in the past decade provides an 
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opportunity to deliver chest compressions with precision.  Precision delivered chest compressions, 
driven by a computer capable of making data driven decisions, have the potential to optimize blood 
flow.  
In animal models, hemodynamic, goal directed CPR, driven by invasive pressure 
measurements, has been shown to improve short term survival, and has been validated in both 
asphyxial and pediatric swine models[65-67].  It has also been shown to improve cerebral 
perfusion and brain tissue oxygenation[68].  There has also been a link established between EtC02 
levels and CPR quality in both in-hospital and out-of-hospital settings.  The swine model of 
resuscitation used in these experiments, in addition to the work described in this dissertation, has 
been commonly used as a translatable model for human cardiac arrest[69] 
In further human studies, an association was found between physiologic monitoring of CPR 
quality and patient outcomes when clinicians monitor either ETCO2 or diastolic blood pressure 
during CPR.  The rates of ROSC improved in the physiologic monitoring group[70].  However, 
when studying associations between physiologic monitoring and survival, only ETC02, when 
titrated to be kept at above a threshold greater than 10mmHg, was significantly associated with 
survival.  This study further validates the need for a multimodal approach to physiologic 
monitoring during CPR. 
There are many questions that must be addressed when designing a chest compression 
device capable of receiving physiologic feedback from a cardiac arrest patient, and subsequently 
adapting its chest compression response to that feedback.  The work described in this dissertation 
seeks to further connect the way CPR is delivered to QECG response and outcomes.  Establishing 
these connections gives further credence to adaptive CPR that could be tailored to the patient, 
etiology, or phase of cardiac arrest. 
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1.6 SIGNIFICANCE AND AIMS 
Cardiac arrest is lethal and survival rates are low.  CPR, the main treatment intervention 
for cardiac arrest, is performed as a 'one size fits all' approach.  The chest compression component 
of CPR can be described by parameters such as rate and depth.  Biosignals received from the 
patient during CPR are a reflection of the perfusion status of the patient, and can be used as a 
surrogate for CPR effectiveness.  There are gaps in knowledge in how biosignals respond to 
changes in chest compression parameters, and no technology exists that completes the feedback 
loop between changes in chest compression parameters, blood flow, and measured biosignals. 
Aim 1 of the work described here covers the development of a mechanical chest 
compression device along with subsequent feasibility tests.  Further animal tests sought to link the 
QECG biosignal to chest compression parameters in a controlled cardiac arrest model.  It was 
hypothesized such an adaptive compression device is feasible, and that certain QECG signals 
respond to specific changes in chest compression parameters.   
Aim 2 of the work seeks to investigate relationships between chest compression parameters 
and QECG in retrospective human clinical data, where measured outcomes such as survival and 
return of spontaneous circulation are available.  It was hypothesized that certain QECG metrics 
measured in the clinical data would be responsive to changes in chest compression data. 
Both aims of the work described in this dissertation seek to answer three primary questions 
in how to complete a 'closed feedback loop' of chest compressions being guided by biosignsls. 
These primary questions include which biosignals to measure, be it a type of QECG or other signal, 
which chest compression parameter to adjust such as chest compression rate, chest compression 
depth, or chest compression duty cycle, and finally how much and when to adjust the chest 
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compression parameter.  Findings from this work seek to fill the knowledge gaps that exist in 
developing an adaptive approach to chest compressions in cardiac arrest. 
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2.0  AIM 1 – VALIDATION OF ADAPTIVE CPR DEVICE  
Aim 1 of this dissertation includes sections that describe the initial feasibility studies 
conducted using the adaptive chest compression device which utilizes physiologic feedback.  Parts 
of text and figures in sections 2.1-2.3 are derived from the publication ‘Feasibility of Biosignal-
guided Chest Compression During Cardiopulmonary Resuscitation: A Proof of Concept’ in 
Academic Emergency Medicine[71].  The primary hypothesis of this feasibility study was that 
such an adaptive chest compression device could be built, and that it would respond appropriately 
to biosignals. 
Aim 1 also describes a computational model that applies an adaptive approach to chest 
compressions in a simulated population of variable physiology.  The adaptive approach adjusts 
chest compression rate, depth, and duty cycle in response to calculated cardiac ouput values 
generated by the model.  We hypothesized that individual chest compression parameters would be 
more influential than other chest compression parameters in affecting the simulated cardiac output 
generated by the model. 
Lastly, Aim 1 includes animal experiments where the adaptive chest compression device 
adjusts specific chest compression parameters while holding all other chest compression 
parameters constant.  The purpose of these experiments was to observe how QECG metrics 
responded to these chest compression parameter changes in controlled setting of an animal model. 
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2.1 DEVELOPMENT OF CPR DEVICE 
Our first task was to engineer and construct an adaptable chest compression device capable 
of receiving biosignals and responding to them according to an algorithm.  We built a custom, 
electromechanically controlled, signal-guided chest compression device. This system included 
three principal components: a computer central processing unit (CPU)-coupled linear actuator 
responsible for piston movement, a signal acquisition unit that collected biosignals, and a main 
control computer that coordinated feedback signals and commands between the actuator and 
biosignal acquisition unit (Powerlab 16/30 Model ML880, AD Instruments) recording at 1000 Hz. 
Chest compressions were delivered by the actuator piston (UltraMotion, Inc., Cutchogue, NY; and 
Moog, Inc., Elma, NY). Guidance signals were then transmitted to MATLAB (Mathworks, Inc.) 
through a custom cross-platform memory sharing script provided by AD Instruments. The layout 
of this design is shown in Figure 11. Using experience from previous swine models, the signal-
guided chest compression device was limited to a maximum depth of 2 inches and a maximum 
rate of 130 compressions/minute.   This was accomplished by programming the actuator piston to 
never accept input from the acquisition device that instructed the device to compress at depths 
greater than 2 inches or at a rate greater than 130 compressions per minute. 
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The signal-guided chest compression device was programmed to make adjustments 
independent of the user. Adjustments to depth and rate would be made only when a preset 
physiologic “threshold” was not met during any given chest compression pause, and CPR 
parameters were changed until the threshold was reached or until the maximum rate and depth 
were reached.  Figure 11 displays an outline of the prototype device in its projection as a closed 
feedback loop.  Figure 12 is a photograph of the prototype device. 
Biosignals from the patient that guide the adaptation of the device are transmitted to 
MATLAB (Mathworks, Inc.) through a custom memory sharing script that was provided by AD 
Instruments. The layout of this design is shown in Figure 11 including one of the first iterations of 
Figure 11: Design of adaptive chest compression device 
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the piston design.  Further iterations of the piston included a suction cup attached to the lower 
portion and interfacing with the chest that aided in active decompression during the upstroke 
movement.  Active decompression has been shown to increase cardiac output and improve survival 
in some studies[72, 73]. 
A graphical user interface was created through MATLAB that allowed for control of chest 
compression rate, depth, and duty cycle.  The user interface also allowed for easy programming of 
chest compression algorithms. 
Limits to the chest compression settings and algorithms were programmed to not exceed 
certain values to guard against too extreme depths and rates that could cause harm to the 
patient/animal.  For example, compressions that are too deep could cause rib fracture. Chest 
compression parameters in the device are limited to a maximum depth of 2 inches and a maximum 
rate of 130 compressions/minute. 
Figure 12: Photograph of adaptive chest compression device 
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The signal-guided chest compression device was programmed to make adjustments 
independent of the user. Adjustments to depth and rate would be made only when a preset 
physiologic “threshold” had not been reached during any given chest compression pause.  Chest 
compression parameters were changed until the threshold was reached or until the maximum rate 
and depth were reached. 
2.2 ANIMAL MODEL OF CARDIAC ARREST 
All animal studies done in this work were performed using a swine model of cardiac arrest 
that has been IACUC approved.   
In the feasibility study, female mixed-breed domestic swine (Sus scrofa) were prepared in 
a standardized fashion.  The animals had a mean mass of 24.1kg and were sedated (Ketamine 
[10mg/kg]/ Xylazine [4mg/kg]), anesthetized (Fentanyl [50mcg/kg loading dose / 50 mcg/kg/hr 
infusion]) and paralyzed (Vecuronium [4mg bolus/2mg additional boluses as needed]).  Following 
endotracheal intubation, the animals were mechanically ventilated (Ohmeda 7000) with room air. 
Central arterial and venous pressure monitoring were measured by using a femoral cut-down 
technique and inserting Millar catheters (Millar Instruments, Houston, TX) to the aorta and right 
atrium.  ECG was recorded and sampled at 1000Hz (Dual Bio AMP FE 135, AD Instruments, 
Colorado Springs, CO).   
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2.3 INITIAL FEASIBILITY STUDY 
The aim of the first feasibility test was to show that the custom-built CPR device could 
respond to biosignals in an appropriate way and independent of the user.  We hypothesized that 
the chest compression device would react appropriately to the biosignals it received. 
2.3.1 Feasibility Experiment Protocol 
The biosignals we investigated in this initial feasibility study were central arterial pressure 
(CAP) and median slope (MS), a QECG metric.  These biosignals were monitored during 3-second 
chest compression pauses every 30 seconds throughout the resuscitation in an effort to reduce 
signal artifact from the chest compressions. CAP was calculated as the mean central aortic pressure 
over a 3-second window of a continuous 1000-Hz sample. MS was calculated as the median of the 
collective sample to sample differences taken from a down-sampled, 250-Hz 3-second window of 
VF smoothed with a 10-point moving average filter. 
The primary outcome we assessed was “appropriate response” of the signal-guided chest 
compression device to biosignals above and below our biosignal threshold. We defined 
“appropriate response” as adherence to a 'threshold' algorithm.   
The ''threshold' algorithm was defined as the device making rate or depth adjustments in 
response to being below a defined biosignal threshold (MS threshold or CAP threshold).  The 
biosignal threshold was arbitrarily set to an optimal level, based on previous swine studies, and 
treated as a target that the device would aim to achieve.  If both the MS or CAP biosignals were 
below their respective thresholds, the device would make incremental chest compression 
adjustments.  In this model, both rate and depth were adjusted simultaneously at increments shown 
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in Table 1.  The biosignals were analyzed every 30 seconds.  If either one of the MS or CAP 
biosignals were above its respective threshold, the chest compression parameters would stop 
adjusting and be held constant by the adjustment algorithm. Table 1 displays example algorithm 
parameters that the chest compression device followed for one animal experiment. 
The general experimental timeline for the initial feasibility study is displayed in Figure 13. 
VF was induced with a 3-second 100 mA transthoracic shock and left untreated for 6 minutes to 
simulate an OHCA.  After 6 minutes following the induction of cardiac arrest, chest compressions 
were initiated using the biosignal chest compression system with 3-second pauses every 30 
seconds for rhythm analysis. If either a biosignal threshold was met (MS or CAP), or if the chest 
Table 1: Example algorithm for feedback CPR 
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compression parameters of rate and depth had reached their maximum limit, a rescue shock (150J, 
Zoll M-Series, Zoll, Chelmsford, MA) was attempted in the subsequent 30 seconds. In the event 
of a failed rescue shock, no further shocks were attempted.  Six animals were used in feasibility 
test. 
The target biosignal threshold was adjusted each experiment in reference to the baseline 
animal biosignal observed during the baseline measurements as well as historical data we had 
observed in past swine models.  Chest compression depth and chest compression rate changes were 
made simultaneously.  The duty cycle of the chest compression was held constant and not adjusted.  
Figure 13 displays the protocol visually for animals after either a biosignal threshold was met, 14 
minutes had elapsed, or ROSC (return of spontaneous circulation) was achieved.  
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If ROSC was achieved after defibrillation, the swine were monitored briefly. While still 
under general anesthesia, surviving animals were euthanized with a rapid IV infusion of 40 mEq 
of potassium chloride.   
2.3.2 Feasibility Study Results 
Our custom device responded appropriately to biosignals by changing its rate and depth. 
All animals exhibited positive improvements in their biosignals. The animals that did not reach 
either of the two biosignal thresholds had their chest compression parameters adjusted until they 
reached the maximum parameter level (depth = 2 inches, rate = 130 compression/min).  
Figure 13: Outline of feasibility study 
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In the six animal trials conducted, defibrillation was attempted on five animals and two 
animals achieved ROSC. A summary of the results can be seen in Table 2.  Four out of six animals 
achieved the maximum final rate of 130 compressions per minute and all animals achieved the 
maximum final depth of 2 inches. 
Figure 14 shows an example experiment for an animal that reached the MS biosignal 
threshold and was successfully defibrillated. Figure 15 shows a separate animal that reached the 
CAP biosignal threshold and was not successfully defibrillated.  
Table 2: Results from feasibility experiment 
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During the course of the resuscitation, three of the six animals improved their biosignals to 
reach the MS threshold, while two of the six animals reached the CAP threshold.  The maximum 
depth of 2 inches was met in all experiments.  In Figure 14 and Figure 15, the top plot tracks the 
change in biosignals (CAP in red and MS in blue), while the lower plot tracks the changes in chest 
compression parameters the device implemented before the biosignal threshold was met.  The 
Figure 14: Example feasibility experiment 
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device appropriately ceased making chest compression adjustments as soon as one of the two 
biosignal thresholds were met.  
The MS threshold was achieved in three out of six animals while the CAP threshold was 
achieved in two out of six animals.  The device responded appropriately in all animals, that is it 
continued making adjustments when biosignal thresholds were not met and correctly halted chest 
compression adjustments once one of the two biosignal thresholds was met. 
Figure 15: Example feasibility experiment 
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2.3.3 Feasibility Study Discussion and Limitations 
The treatment of cardiac arrest remains a “black box” in terms of providing optimized care 
for patients. The variable nature of patients necessitates an adaptive approach to CPR. Mechanical 
chest compression devices, when coupled to a smart CPU capable of receiving biosignal input, are 
adaptable to the variable nature of patients. 
Our approach very much depends on how accurately our adaptive device is able to acquire 
and interpret biosignals and in turn relate those biosignals to the quality of perfusion generated by 
the chest compressions. In a prehospital setting, however, it would be required that these biosignals 
are noninvasively measured. Biosignal metrics used in our study such as MS QECG are 
noninvasive and readily available and are derived from the ECG, which is ubiquitously recorded 
in ambulances for every cardiac arrest patient. A link could therefore be established between 
existing defibrillator monitors and a biosignal-driven CPR device. 
Our findings provide preliminary evidence that a beneficial increase in perfusion may be 
achieved in cardiac arrest patients by linking the delivery of CPR to invasive and noninvasive 
biosignals. With more optimal CPR given to patients, patient survival outcomes could be 
improved. While we have focused on using the biosignals to modify the chest compressions 
provided by a mechanical CPR device, this feedback could likely also be given to EMS personnel 
providing manual compressions. 
Limitations include translating these findings from a controlled animal lab setting to 
humans as well as QECG only being available for analysis in VF cardiac arrests.  We also 
acknowledge that the threshold settings need to be further studied to understand what a reasonable 
positive increase in biosignals would be expected in a successful adaptive approach.   
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2.4 CPR IN A COMPUTATIONAL MODEL 
After the initial feasibility of feedback driven chest compressions was established in an 
animal model described in the previous section, further gaps in knowledge remained that 
encompassed which chest compression parameter would have the greatest effect on measurable 
biosignals.   To explore this issue more in depth, a computational analysis was conducted to test 
changes in chest compression in a simulated patient population that had variable chest sizes and 
physiology.  In this computational model cardiac output was used as the measured biosignal.  The 
simulation would adjust chest compression parameters to optimize the cardiac output biosignal. 
This computational model tested the theory that 'one size fits all' may not be optimal, especially 
when dealing with a variable population.   
We hypothesized that an adaptive approach in a computational model involving chest 
compression parameter adjustments would yield greater cardiac outputs at the end of the 
simulation's iterations.  It was also hypothesized that chest compression depth adjustments would 
have the greatest effect on final cardiac output in the adaptive model based on previous anecdotal 
observations in our animal lab.   
Simple computational models have long been used to simulate pressure, volume, and flow 
relationships in the circulatory system.  A computational model provides the ultimate controlled 
setting to study hemodynamics.  To simulate the basic conditions of a feedback CPR approach in 
patients with variable physiology, we collaborated with Dr. Charles Babbs at Purdue University, 
an expert in computational models of CPR.  Dr. Babbs has developed computational models for 
various methods of chest compression techniques.[74-76]  The purpose of using this collaborative 
model was to establish a basic foundation of various hemodynamic responses to varying chest 
compression rate, depth, and duty cycle in patient models of varying body sizes. 
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2.4.1 Model Design 
The model used for chest compression in this study included 5 compartments: a chest pump 
connected in series with supraphrenic and subphrenic aortic segments and corresponding upper 
and lower body caval segments.  There are input and output valves in the chest pump component 
of the model.  Chest compressions in the model create thoracic pressure and was linearly related 
to the ratio of chest compression amplitude to chest diameter.  The outline of this model simplified 
to compartments can be seen in Figure 16. 
100 simulated patients were used in the simulation where each patient was randomly 
assigned a body weight ranging from 40 to 110 kg. The mean body weight in the simulated patient 
population was set to 70 kg and the standard deviation of body weight was set to 15 kg.  To simulate 
Figure 16: Computational chest compression model 
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an average patient of a particular body size, vascular compliances were scaled in proportion to 
body weight, chest diameter is scaled in proportion to the 1/3 power of body weight, and vascular 
resistances were scaled in proportion to the negative 2/3 power of body weight. Vascular resistance 
in this chest compression model can be thought of as the resistance to forward blood flow due to 
the 'chest pump' component of the system.  Cardiac output is then calculated as the difference in 
pressures across component compartments divided by the resistance.  A sample calculation is 
shown in Figure 17.  Microsoft Visual Basic Version 6.0 (Redmond, WA) was used for 
computational analysis. 
Chest diameters used in the simulation is taken as the absolute distance between 
the chest and back similar to the anterior-posterior (AP) diameter used in reference for current 
AHA defined chest compression guidelines.[1]  These average values are then multiplied by a 
Figure 17: Example cardiac output calculation 
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Gaussian random variable with a mean of 1.0 and a standard deviation of 0.1 to represent a 
particular randomly selected patient.  These physiologic variables were generated randomly to 
simulate the variable population of cardiac arrest patients.  There were a total of 100 subjects 
simulated and each subject went through an iteration of standard chest compressions that were not 
adjusted as well as an iteration of adaptive chest compressions that were adjusted based on the 
cardiac output. 
Chest compression adjustments in the adaptive model were performed according to the 
following guidelines.  First, cardiac output is computed for standard chest compression (100/ min, 
5 cm depth, duty cycle 50%) in the randomly selected patient model.  Then the three chest 
compression variables (rate, depth, and duty cycle) are adjusted simultaneously using computer 
simulated evolution.  Each chest compression variable was randomly increased or decreased by 
Figure 18: Adjustment algorithm 
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5% after the cardiac output was determined for a 5 second test run of CPR.  If the new computed 
cardiac output was 2% or better than the previous computed cardiac output value, the chest 
compression adjustment was preserved.   Otherwise the chest compression adjustment is reversed.  
This process was repeated for 100 iterations to obtain an individually adjusted chest compression 
technique.  A realistic hard limit on chest compression depth of 50% of chest diameter was 
imposed.  This limit was set to meet the clinical reality that chest compressions deeper than 50% 
of the chest diameter would be deleterious to the patient.   This adjustment algorithm is shown in 
Figure 18. 
2.4.2 Model Results 
A histogram of final cardiac output values was generated for the first 100 patients of the 
model and can be seen in Figure 9.  In Figure 14 CO is the final output of the adaptive chest 
compression model divided by the cardiac output of the standard ‘fixed’ chest compression model 
in the same simulated subject to create a cardiac output ratio for each reflecting the effect of the 
adaptive model on cardiac output compared to the standard model of cardiac output.  The 
histogram shows that the adaptive chest compression simulation improved final cardiac output by 
a nearly 3-fold increase.  This represents a near 3-fold increase in the forward blood flow when 
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compared to a standard chest compression approach.  Standard CPR works well in models with 
very thin chests front to back, but not so well in others.  
After the end of all 100 simulations The final values of chest compression parameters 
shows that the increased amount of output is largely due to increased chest compression depth, 
rather than rate or duty cycle changes.  Rates remained at 100/min and duty cycles remained at 
50%.  The mean final ratio of the adaptive model final cardiac output to the standard model final 
cardiac output was 1.77.  The final mean chest compression depth value was .48 inches in the 
adaptive model and the final mean chest compression rate value was 100 compressions per minute.  
Figure 19: Final cardiac output in adaptive model normalized to fixed model 
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A 3D plot of the final rate and depth values by simulated individual in the adaptive model along 
with its respective final normalized cardiac output, can be seen in Figure 20. 
This computational analysis shows that in simulation, improving blood flow due to chest 
compressions depends on increasing chest compression depth.  This observation was found in the 
adaptive computational model in the setting of random variation in the resistive properties of the 
systemic circulation as well as variation in chest diameter across patients. 
Figure 20: Final cardiac output, final rate, and final depth 
 47 
This model is limited by its simplicity in modeling complex physiologic phenomena, but 
provides the early basis that physiologic variability matters in an adaptive approach to chest 
compressions in CPR.  The model is also limited in that chest compressions are given as a 
rectangular pulse waveform which may not reflect chest compression waveforms given in a real 
life clinical setting that may have rounded edges compression waveforms.   
An additional factor worth considering in the computational model concerns whether the 
chest compression adjustment used in this model would be the optimal adaptive approach to 
cardiac output feedback driven chest compressions.  The use of 5% adjustments in chest 
compression values reacting to at least 2% changes in cardiac output was chosen only based on 
the fact that these values seemed clinically reasonable.  Five seconds was chosen as the amount of 
time after an adjustment to make a cardiac output calculation.  Further work in computational 










2.5 QECG IN RESPONSE TO VARYING CPR IN AN ANIMAL MODEL 
To further examine the effect of varying chest compression rate, depth, and duty cycle on 
biosignals, a second animal study was conducted.  This animal study was an important follow-up 
to the findings generated by the simulation data and initial feasibility study.  However, unlike the 
simulation which used cardiac output as the biosignal, this second animal trial focused on QECG 
as the biosignal.  Invasive measurements such as cardiac output are not available in the out-of-
hospital setting and this animal study was conducted in an attempt to monitor a noninvasive 
biosignal in the context of changing chest compression parameters.  QECG is a readily available 
non-invasive biosignal for OHCA patients.  
The hypothesis of this second animal study was that in a controlled environment QECG 
metrics would respond to changes in chest compression rate, chest compression depth, or chest 
compression duty cycle.  From the results in the computational model, it was hypothesized that 
chest compression depth would have the most significant effect.  These studies sought to provide 
answers to the first two questions posed in the significance and aims discussion in Section 1.6 
concerning which chest compression to adjust and which biosignals to monitor in an adaptive 
model of chest compression delivery. 
2.5.1 Animal Model Methods 
In this study, 12 mixed-breed domestic swine were sedated, anesthetized and paralyzed, 
followed by endotracheal intubation and mechanical ventilation. Animals were instrumented with 
a battery of physiological sensors, including multi-lead ECG, recorded continuously with a high-
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fidelity data acquisition unit at 1000Hz. VF was induced with a 3-second 100mA transthoracic 
shock.  
After 7 minutes of untreated VF, animals were randomized to receive continuous CPR with 
our custom-built robotic device.  Animals were grouped using 1 of 6 pre-programmed, cross-over 
2-phase CPR schemes.  These schemes are shown visually in Figure 12.  Each scheme varied 1 
parameter in 5 x 1-minute intervals while holding other parameters unchanged.  There were 2 
phases of the 5 x 1 minute intervals, hence the crossover design to obtain as much data per animal 
as possible.  This experimental setup is shown in Figure 21, 22, and 23.   
Each grouping contains one chest compression variable that changes once a minute which 
is either chest compression rate, chest compression depth, or chest compression duty cycle.  All 
parameter changes cycle in sequence and include values of ‘low’, ‘medium’, ‘high’, and ‘very 
high’.  These values are shown in Table 3.   
We hypothesized that a linear response in QECG would result in the parameters studied 
due to the fact that the ranges included in chest compression parameters did not include ‘extreme’ 
values.  For example, the range of chest compression values used was from 60 cpm to 120 cpm.  
A range that may have elicited a non-linear response would be 10cpm to 200cpm where the 
extreme values of chest compression parameters, such as compression given at 200cpm, would 
have disrupted any linear increase in response observed in the range of 60cpm to 120cpm. 
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Figure 21: Analysis Approach A 
Figure 22: Analysis Approach B 
51 
Figure 23: Crossover design of animal experiment
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Chest compression adjustments were made every minute, with a baseline of one minute of 
‘standard’ CPR parameters before each adjustment phase.  QECG characteristics (AMSA, MS, 
CF, LAC, and DFA) were calculated at the end of each 1-minute interval and compared against 
rate, depth and DC in both phase 1 and phase 2. 
Figure 24: Chest compression group classification 
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 Change in QECG across adjustment minute was also calculated and compared to each 
chest compression parameter.  Figures 10 and Figure 11 explain further this experimental setup. 
That is, both the QECG values at minute's end, and change over minute were taken.   
Phase 1 and Phase 2 analyses were performed separately.  Phase 2 results were inherently 
limited by what had occurred in phase 1, but were analyzed nonetheless to extract as much 
information as possible from each animal.  The QECG values used in these animal studies were 
AMSA, MS, CF, LAC, and DFA.  Their equations used for their calculation are shown in Figures 
5-9 described in the introduction of this work.  The frequency distribution calculated in centroid
frequency equation was found using a fast fourier transform in MATLAB.   The technique for the 
DFA calculation involved calculating the F term in Figure 9 in a technique outlined by Lin et al. 
and used in our Matlab code[58]. 
To test for relationships between the QECG and chest compression parameters, simple 
linear regression analysis was performed.  We believe that this was the most appropriate test as 
past clinical evidence has shown that survival has a somewhat linear dependence on rate and depth 
for rates up to 120/min and depths just past 2 inches.  It was assumed that since this linear 
relationship held for survival, a similar effect would be shown for QECG.  There has been less 
evidence for these associations in duty cycle studies.  
The timing of the QECG calculations were calculated using two separate methods.  The 
first method involved calculating the QECG value using the last 3 seconds of every minute where 
a chest compression parameter was changed.  The second method involved calculating the change 
in QECG over the minute using the change in QECG in the first and last 3 second interval.  
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2.5.2 Animal Model Results 
Linear regression analysis was performed for both phase 1 and phase 2 of the crossover 
experimental design.  R2 values for each linear fit in phase 1 along with their associated p values 
are shown in tables 3 and 4 respectively.  These tables represent phase 1 changes with the 'end of 
minute' technique used (Analysis Approach A).  Plots shown in the following section are linear 
regression tests that contained significant results (yellow box).  All plots that contained only 
insignificant results can be found in Appendix A.  Error bars in all graphs are standard deviation. 
The QECG metrics median slope (MS), centroid frequency (CF), and log absolute 
correlation (LAC) had significant linear responses to rate changes when using Analysis Approach 
A during the Phase 1 section of the experiment.  Plots of these responses are shown in Figures 25, 
Table 3: R squared values in phase 1 at minute end 
Table 4: P values in Phase 1, QECG values taken at minute end 
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26, and 27.  Plots with a yellow box represent significant linear responses.  Plots for the non-
significant QECG responses in AMSA and DFA are shown in Appendix B.  Depth changes and 
duty cycle changes did not produce a significant linear response in any QECG metric. 
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Figure 25: Median slope response to CC  
changes in Phase 1 (Analysis Approach A) 
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Figure 26: CF response to CC changes 
in phase 1 (Analysis Approach A) 
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Figure 27: LAC response to CC changes 
 in Phase 1 (Analysis Approach A) 
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In the analysis looking at the change in QECG over minute (Analysis Approach B), no 
linear regression was significant.  The R2 values, p values are shown in Table 5 and Table 6 
respectively.  The figures for these non-significant results are shown in Appendix B.   
To summarize the Phase 1 findings, MS, CF, and LAC had significant linear responses 
when assessing the QECG values at the end of each change in rate (Analysis Approach A).  After 
assessing Phase 1 through the use of change in QECG value over minute (Analysis Approach B), 
no significant linear response was observed.   
The same analysis approach applied to Phase 1 was applied to Phase 2.   Phase 2 results 
are shown for both QECG values taken at minute end (Analysis Approach A) and change over 
minute (Analysis Approach B).  
Analysis Approach A R2 values and p values are shown in Table 7 and Table 8 respectively 
for phase 2. Plots of significant results are shown in Figure 28 and Figure 29.  Plots that show all 
non-significant results are shown in Appendix B.  AMSA responded linearly to changes in chest 
compression duty cycle and MS responded linearly to changes in chest compression rate.  Median 
Table 6: P values in phase 1, QECG taken as change over minute 
Table 5: R squared values in phase 1, QECG values taken as change over minute 
60 
slope values responded as a decreasing linear trend in contrast to a positive linear trend seen in 
Phase 1.  Bars in these graphs are standard deviation. 
Table 8: R squared values in phase 2, QECG taken at minute end 
Table 7: P values in phase 2, QECG values taken at minute end 
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Figure 28: AMSA response to CC changes 
 in phase 2 (Analysis Approach A) 
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Figure 29: Median slope response to CC changes 
 in Phase 2 (Analysis Approach A) 
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In the Phase 2 analysis for QECG values taken as change over minute (Analysis Approach 
B), no QECG metric exhibited a linear response to changing chest compression parameters 
identical to the results observed in Phase 1.  These findings are displayed in Table 9 and Table 10. 
In summary of the Phase 2 findings, AMSA exhibited a positive linear response to duty 
cycle changes and MS exhibited a negative linear response to chest compression rate changes.  
These significant findings were found using the QECG values observed at the end of each minute 
of chest compression parameter change (Analysis Approach A). 
There is no clear indication whether the 'change over minute' approach (Analysis Approach 
B) or the QECG value taken 'at minute end' (Analysis Approach A) is more appropriate for this
analysis.  Both were reported and analyzed in an effort to study QECG responses as thoroughly as 
possible. 
There are some limitations in approaching the data with linear regression analysis.  While 
we hypothesize there is likely a 'dose response' in QECG generated by changes in chest 
Table 9: R squared values in phase 2, QECG values taken as change over minute 
Table 10: P values in phase 2, QECG values taken as change over minute (no significance)
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compression parameters, for example increasing chest compression rates would cause a 'dosed' 
increase in QECG, we are assuming that a dosed response is linear.  The reasoning behind this 
assumption is based on existing evidence from the AHA that recommend a chest compression rate 
between 100 and 120 compressions per minute for adults, an increase  in chest compression rates 
from 80 to 110 should theoretically produce a positive response in QECG[1].  The reasoning 
behind a dosed linear response of QECG to chest compression changes is also based on reasoning 
that extreme values of chest compression parameters such as a chest compression rate of 20 or a 
chest compression rate of 200 would be the driving contributor to any non-linear response.  
Extreme values of chest compression parameters were left out of these experiments.  The same 
assumption is made in this analysis for chest compression depths that range from 1.50-2.25 inches 
and duty cycle values from 10% - 75%. 
Analysis of Variance (ANOVA) would be a more appropriate response if non-linearity was 
assumed and this approach was tested as well.  The ANOVA approach to the QECG/chest 
compression parameter relationships did not produce any significant associations across all QECG 
and chest compression parameters in both phase 1 and phase 2.  Future experiments would likely 
require studies with greater sample size to increase the power to detect potential differences. 
These animal data demonstrate some linear dependence for chest compression rate and 
select QECG values, whereas this association was not seen for depth and duty cycle.  These data 
are in contrast to the initial simulation data that showed depth was the most influential chest 
compression variable in a simulated variable population.  However, it is noted that the swine used 
in these studies were similar in size.   
Both simulation data and animal data have limitations.  The simulation is a simplified 
model of the circulatory system and may not reflect more complex physiologic responses to 
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changes in chest compression.  Direct comparisons of the results in simulation and animal studies 
may not be appropriate as different biosignals were measured.   The simulation data explored 
cardiac output response to adaptive CPR whereas the animal model primarily investigated QECG. 
The decision to investigate QECG in the animal model was influenced by its feasibility of use in 
an out-of-hospital setting where invasive measures are unavailable. 
These initial feasibility, simulation, and animal data provided us with evidence that an 
adaptive approach to chest compressions in CPR was feasible, and that chest compression rate may 
influence QECG changes early in cardiac arrest based on the phase 1 animal trial results.  The 
computational model also provided evidence that chest compression depth plays an important role 
in generating cardiac output in a simulated variable population.   Our next goal was to understand 
the relationship between chest compression changes and QECG in human clinical data. 
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3.0  AIM 2 – TRANSLATION OF FINDINGS TO CLINICAL DATA 
The focus of Aim 2 was to translate the findings from Aim 1 collected on computational 
and animal data to human clinical data.  We hypothesized that QECG metrics would be predictive 
of defibrillation outcome and chest compression parameter rate and depth would be predictive of 
survival outcomes.  We also hypothesized that the change in QECG value before and after 
durations of chest compression bouts would be linearly dependent on the chest compression 
parameters within that bout. 
3.1 CLINICAL DATA FROM ROC TRIALS 
The work discussed in Aim 2 of this dissertation is derived from data collected from human 
cardiac arrest clinical trials.  The source of cardiac arrest signal data was the Resuscitation 
Outcomes Consortium (ROC), a multi-site project that sought to address epidemiologic and 
clinical questions involving cardiac arrest with the use of randomized controlled clinical trials 
(Morrison 2008).  The ROC Epistry was designed with 11 geographical sites within the US and 
Canada, which included the Pittsburgh Regional Clinical Center.  
Of these 11 sites, the ROC network consisted of 36,000 EMS professionals within 260 
EMS systems.   This network covered an estimated 24 million people from urban, suburban, and 
rural communities, and transported patients to 287 different hospitals. (Davis 2007) The ROC 
provided us with comprehensive patient data that includes such variables as witnessed status, chest 
compression depth, and hospital discharge outcomes. 
67 
For patients to be eligible to be included in the ROC Epistry, they needed to be 18 years or 
older and have sustained non-traumatic cardiac arrest.  The ROC Epistry collected many variables 
from each cardiac arrest patient, both physiologic and demographic.    
3.2 SPAIN (SIGNAL PARSING AND INTEGRATION) 
To better organize the cardiac arrest cases and the type of signals involved, a graphical user 
interface (GUI) was developed in MATLAB to easily facilitate storage of thousands of hours of 
Figure 30: Custom graphical user interface 
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CPR data.  This database GUI was developed originally by Dr. David Salcido and named Signal 
Parser and Integration (SPAIN).  A sample screenshot of the SPAIN can be seen in Figure 30. 
In SPAIN, each cardiac arrest case integrates observable time-dependent signals that the 
user can scroll through and search for treatment specific events such as timing and gaps of chest 
compressions and defibrillation times. 
The organization of SPAIN also standardized multiple ECG sources into one 
continuous signal.  This is important in the ECG analyses conducted in the study as it can 
concatenate ECG data received from different sources (AED or EMS monitor) that are used on the 
same case.  This commonly occurs between the ‘hand-off’ between the Fire crew that often arrive 
to the patient first, and the EMS crew who arrive second. 
3.3 CLINICAL DATA – QECG, CPR, AND OUTCOMES 
Following the build-up of the graphical user interface to allow for easy compiling of ROC 
cases in the shock studies discussed in this work, case data from non-traumatic EMS-treated 
cardiac arrests from 2011 to 2015, enrolled in the Continuous Chest Compression (CCC) trial 
conducted by the Resuscitation Outcomes Consortium (ROC), were used and obtained from 7 
ROC sites. 
The CCC trial compared uninterrupted chest compressions against the historically used 
30:2 compression to ventilation ratio approach. Patients in the trial were randomized through an 
emergency medical services (EMS) agency-level cluster randomization design to receive either 
30:2 or CCC CPR. 
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We sought to first characterize the distribution of QECG and CPR parameters in the clinical 
dataset, next show traditional relationships of QECG values and CPR parameters to outcomes, 
then to establish any predictive relationship between QECG and CPR parameters.  We 
hypothesized that some of the QECG metrics would more effectively predict successful shock 
defibrillation and that specific chest compression parameter values within a cardiac arrest would 
predict survival outcomes.  Successful defibrillation in this study was defined as return of 
organized rhythm (ROOR).  ROOR was determined by visual inspection of the ECG signal directly 
following the shock attempt. A positive ROOR finding was determined if the morphology of the 
ECG in the post shock period resembled an organized rhythm capable of perfusion. 
3.3.1 QECG and CPR Relationship to Outcomes 
The first step in analyzing clinical QECG and CPR parameters in the second aim of the 
work was to establish relationships between preshock QECG and shock outcome as well as chest 
compression parameter values and survival.  These relationships have been described in past 
literature from separate clinical trials, but not in our dataset.  It was hypothesized that QECG values 
would have a predictive relationship with shock outcome.  It was also hypothesized the rate and 
depth chest compression parameters would be predictive of survival outcome.   
We examined cardiac arrest cases from the ROC Continuous Chest Compression trial 
(CCC) to establish relationships between QECG metrics directly before every shock.  All ECG
data were obtained from prehospital EMS-treated cardiac arrests from 2011 to 2015 that were 
enrolled in the CCC trial.  These data were obtained from 7 ROC sites.  Data were downloaded 
from monitors using manufacturer software.  Signal data were then extracted from the downloaded 
files using a custom MATLAB program (Mathworks Inc, Natick, MA).   
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These next sections discuss prediction models for two sub-analyses within the CCC dataset. 
In the first sub-analysis, QECG available before a shock as well as available demographic data are 
assessed for their ability to predict ROOR.  The other sub-analysis characterized chest compression 
parameters within a cardiac arrest case and its ability, along with demographic data, to predict 
survival. 
3.3.1.1 Methods 
ECG and CPR process waveforms were extracted from electronic defibrillator files through 
a custom-built MATLAB (Mathworks Inc., Natick, MA) program.  The preshock interval for each 
shock was automatically isolated for analysis from all identified shocks of the cases that had 
complete ECG records.  An example of one such preshock pause is shown in the left side of Figure 
25 before the ECG spike due to defibrillation.  Pre-shock QECG measures, including AMSA, MS, 
CF, LAC, and DFA were calculated in all available 3 second segments preceding defibrillation 
and averaged, excluding segments with compression artifact.  Compression artifact was assessed 
in the preshock ECG both by visual inspection, and by exclusion of non-physiologic AMSA values 
within the ECG (AMSA values greater than 100).  To ascertain whether there was successful 
defibrillation, ROOR was assessed by visual inspection of the ECG during the largest compression 
gap in a three-minute period post defibrillation.  If there were no gaps in chest compressions for 
three minutes post shock, ROOR was assessed to be unsuccessful.  
QECG metrics were calculated as the mean of all available consecutive 3 second ECG 
segments that were free of compression artifact.  All available, artifact free ECG was used by 
analyzing the last compression before the shock.  If there were no compressions before the shock, 
the last available 5 seconds were used for analysis. Metrics included in all shock studies included 
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AMSA, MS, CF, DFA, and LAC.  All QECG metrics were calculated identically to those in the 
swine studies in Aim 1 according to Figures 5-9. 
 CPR parameters were calculated using MATLAB code to automate extraction of bouts of 
CPR.  Parameters collected included chest compression rate, chest compression depth, chest 
compression duty cycle, duration of the chest compression bout, and chest compression fraction.  
Figure 31: Equations for chest compression parameters 
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A ‘dosed’ version of rate, depth, and duty cycle was also calculated by multiplying the rate, 
depth, or duty cycle of a bout, by its respective bout duration.  We felt that this ‘dosed version’ 
would account for any time dependency not explained by rate, depth, or duty cycle independent of 
themselves.  Equations of how each parameter was calculated as well as visual representations of 
what they characterize can be seen in Figure 31.  The chest compression parameter used in the 
prediction model for survival, was the average parameter across the entire case.  For example, 
chest compression depth when used as a predictor in the survival model was average chest 
compression depth during resuscitation.  Time dependent chest compression variables such as 
chest compression rate excluded gaps in compressions greater than 2 seconds as well as pauses for 
defibrillation attempts. 
Survival to hospital discharge was ascertained by data extractors reviewing prehospital and 
hospital records for each case.  Cases were excluded from survival calculations if outcomes were 
missing.  Logistic regressions were performed with STATA (StataCorp LP, College Station, TX). 
Mixed effect univariate logistic regression was performed on QECG data to predict shock outcome 
(ROOR).  A multivariate mixed-effect model was performed as well for QECG and ROOR 
outcome.  Both univariate and multivariate logistic regressions were performed for CPR 
parameters and survival outcome. 
Receiver operator curves (ROC) were generated for QECG prediction of ROOR as well as 
QECG prediction of survival.  The first available QECG value was used for survival prediction. 
DeLong's comparison test was used to test the null hypothesis that the area beneath the curve 
(AUC) among the five QECG predictors would be the same.  DeLong's test was used both for 
ROOR prediction and survival prediction. [77] 
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After AUC similarity across all QECG predictors were tested Delong's test was performed 
again for the metrics that performed the best in the initial analysis that contained all five QECG 
predictors.  This secondary analysis was used in both QECG prediction of ROOR and first 
available QECG prediction of survival. 
3.3.1.2 Results 
4,297 total shocks were found in 1,573 unique OHCA cases.  ROOR rate per shock was 
20.9% and overall survival was 12.99%.  Survival data were available in 1,255 cases and depth 
data were available in 257 cases containing 787 individual shocks.  Histogram distributions of the 
Figure 32: QECG parameter distribution 
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QECG parameter distribution data and chest compression parameter distribution can be seen in 
Figure 32 and Figure 33 respectively. 
Figure 33: Chest compression parameter distribution 
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Demographic data were first assessed in the QECG-ROOR dataset to test their predictive 
ability independent of QECG predictors. It was hypothesized that a positive witnessed status and 
younger age would be associated with ROOR.  Mixed effect logistic regression model was used 
and results are displayed in Table 11.  Age and the first rhythm being a shockable VF or VT were 
the only significant predictors of ROOR.  Interestingly, an older age was associated with a higher 
likelihood of ROOR. 
Next, univariate mixed logistic models were performed for all five QECG predictors for 
ROOR.  These regression analyses were performed on the first CCC dataset sub-analysis described 
above that includes preshock QECG values paired with its subsequent ROOR assessment. To 
confirm agreement with evidence from past QECG studies and literature which described 
associations between QECG value and shock outcome, we hypothesized that all five QECG 
predictors would be significantly predictive of ROOR.   We used a mixed effect logistic regression 
Table 11: Demographic logistic regression for ROOR in CCC cases with shocks 
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approach that controlled for multiple shock attempts and ROOR outcomes within the same cardiac 
arrest case.  Demographic data were left out of these initial QECG univariate models in order to 
observe QECG prediction of ROOR solely based on the quantifiable VF properties.  The results 
of the univariate analyses are shown in Table 12.  All five QECG metrics were significantly 
predictive of ROOR. Collinear analysis conducted in STATA showed that the the greatest 
correlation coefficient among the QECG predictors as .5425.  We therefore treated each QECG 
metric independently. 
To follow up on the univariate models of ROOR prediction by QECG metrics, a 
multivariate logistic regression was performed that combined all five QECG metrics. It was 
hypothesized that some of the QECG metrics in the univariate analysis would drop out or become 
insignificant when included in the multivariate model.  The multivariate model results are shown 
in Table 13.   
Table 12: Mixed-effect univariate logistic regression for ROOR based on QECG value 
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 Inclusion of variables into multivariate models was defined at a significance level of p 
<.15.  In the multivariate model, centroid frequency dropped out of the model with a p value of 
.713.  Possible contributing factors for the inferiority of the centroid frequency QECG predictor in 
the multivariate model include the absence of an amplitude component in the centroid frequency 
metric. 
After analyzing the first CCC subanalyses concerning QECG prediction of ROOR, the 
following regression models were performed using the second CCC data subanalyses which 
covered chest compression parameter values averaged over the course of an entire cardiac arrest 
case and matched to each case's survival outcome.  Univariate logistic regression analysis was 
again performed for chest compression parameters and their predictive ability of survival.  Past 
literature suggested evidence that demographic data, witnessed status, and chest compression rate 
Table 13: Mixed-effect multivariate logistic regression for ROOR based on QECG value 
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and depth would influence survival outcome.[1]  We hypothesized that both these chest 
compression parameters would be predictive of survival.  Demographic predictors are first shown 
in Table 14 independent of chest compression parameter predictors.  
The demographic analysis showed that increasing age significantly decreased the 
likelihood of survival when controlled for bystander witness status and sex.  This finding was in 
contrast to the QECG-ROOR data subset that showed that increasing age increased the likelihood 
of ROOR.  A confirmed bystander witness status was significantly associated with an increased 
likelihood of survival when controlled for age and sex.  Sex was not significantly predictive of 
survival.  Having a first rhythm that was shockable was also predictive of survival. 
Following the analysis using solely demographic data to predict survival, univariate 
logistic regression models for all chest compression parameters and their predictive ability of 
survival were assessed.  The results of the univariate models of chest compression parameter 
prediction of survival are shown in Table 15.   
Table 14: Demographic logistic regression for survival 
79 
Compression rate and average chest compression bout duration were predictive of survival. 
Older age also was found to lower the likelihood of survival.  These data align with previous 
findings in the literature that show that chest compression rate is an important predictor of 
outcomes[31].  Chest compression depth however was not significantly predictive of survival in 
our models.  
In the final model, both CC parameter and demographic data were used in a multivarariate 
logistic approach to predict survival.  Only variables that were significant in the univariate models 
(p<.05) were used in the multivariate model.  These results are shown in Table 16.  The results 
demonstrate that when controlling for demographic data, chest compression rate drops out of the 
predictive model leaving only chest compression bout duration as a significant predictor of 
Table 15: Univariate logistic regression for survival outcome based on CPR parameters 
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survival.  The large effect of VF/VT status at first rhythm seemed to have largely blunted any 
effect CC rate had on survival outcomes. 
 
A ROC curve was generated for the multivariate model that incorporated both chest 
compression predictor variables and demographic predictor variables.  This curve is shown in 
Figure 34.  The multivariate model produced an area under the curve (AUC) value of .7488.  The 
multivariate logistic regression and ROC curve demonstrate that survival can be predicted using 






Table 16: Multivariate logistic model for survival using CC parameter and demographic data 
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To visualize the QECG metrics' ability to predict outcomes ROC curves were constructed 
for QECG prediction of ROOR as well as first QECG assessed in the cardiac arrest case and its 
prediction of survival.  Delong's comparison test was performed to assess similarity among area 
under the curve (AUC) values[77].  A large value of AUC indicates a strong predictive ability in 
reference to sensitivity and specificity properties. These results and plots are shown in Figure 35 
and Figure 36 respectively. 
Figure 34: ROC curve for multivariate model of survival prediction 
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Figure 35: QECG prediction of ROOR 
83 
Figure 36: First QECG prediction of survival 
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3.3.1.3 Discussion of ROOR and Survival Prediction Results 
The outcome measurements of ROOR and survival paired with logistic regression models 
performed demonstrate the predictive ability of QECG metrics for ROOR and chest compression 
variables for survival.  All QECG values were strongly predictive of ROOR, however only chest 
compression rate and bout duration time were predictive of survival. 
The receiver operator curve analysis demonstrates that the AMSA and MS QECG metrics 
were the strongest predictors of ROOR.  The AUC of CF, LAC, and DFA when compared to the 
AUC of AMSA and MS were lower in the initial ROC analysis.  In the secondary ROC analysis 
in which the CF, LAC, and DFA metrics were removed, there was no significant difference in 
ROOR predictive ability of AMSA and MS.  The cause of the inferiority of CF, LAC, and DFA in 
these predictions when compared to AMSA and MS is unclear.  A possible reason for their 
underperformance in prediction may involve the composition of VF characteristics each metric 
encompasses.  The AMSA and MS metrics may more comprehensively capture the relevant VF 
changes that reflect coronary perfusion, prediction of ROOR, and prediction of survival. 
These initial studies involving QECG prediction of ROOR and chest compression 
parameter prediction of survival studies are limited in a number of ways.  Our use of ROOR to 
characterize successful cardioversion of VF is disadvantaged in that it has the possibility of 
classifying ROOR as PEA.  In this scenario ROOR is classified as a favorable outcome but is 
actually non-pulsatile and unfavorable.  Return of spontaneous circulation (ROSC) would be the 
most desirable shock outcome, but we could not decisively determine ROSC status without verbal 
confirmation of a pulse being palpated by the medics.  We did not have any available audio records, 
therefore we used ROOR as our shock outcome variable.  Another limitation in the study is the 
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lack of available long term survival status.  We are also limited in the number of cases that did not 
have depth data. 
3.3.2 Change in QECG (dQECG) in Response to CPR Parameters 
After demonstrating the predictive ability of QECG for shock outcomes and CPR 
parameters for survival outcomes, we sought to next establish relationships between the QECG 
and chest compressions parameters.  This would help ‘complete the loop’ of feedback between 
biosignals (QECG) and CPR parameters that our adaptive CPR device is based on. 
The hypothesis in these analyses was that changes in QECG metrics over bouts of chest 
compressions would respond to specific chest compression parameter values such as chest 
compression rate, chest compression depth, or chest compression duty cycle.   Cumulative factors 
of these parameters were also considered by using ‘dosed’ versions of the chest compression 
metrics that took into account the time length of each bout in addition to its average parameter 
value across the bout.  Both univariate and multivariate models containing chest compression 
parameters as well as demographic data were used in models to predict change in QECG values 
3.3.2.1   Methods 
To translate the QECG and chest compression parameter findings from the animal lab to 
our clinical data, an analysis was conducted again on the CCC trial clinical data.  We hypothesized 
that some chest compression variables would be predictive of change in QECG (dQECG) values 
over periods of CPR.   
Case data from the CCC trial were included in this analysis only if chest compression data 
were available, allowing us to look at rate, depth, and duty cycle parameters.  1,099 cases from the 
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CCC trial met these criteria, producing 25,210 bout-gap intervals. A representative example of a 
bout-gap interval is shown in Figure 37. 
We defined each dQECG using available bout-gap intervals in the CCC case data.  Bout-
gap intervals were defined as time periods of CPR, uninterrupted by shock attempts, that included 
time intervals of CPR, 'bouts', and time intervals of breaks in CPR greater than two seconds, 'gaps'. 
An example bout-gap interval can be seen in Figure 37.  Gaps in this dataset had to be at least two 
seconds long.  Each dQECG represented the difference between the QECG value in a 2 second 
window immediately after the CPR bout and a QECG value in a 2 second window immediately 
before the CPR bout.  
Figure 37: Example bout-gap interval 
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Chest compression parameters were again calculated according to the equations in Figure 
31, and QECG values were calculated according to the equations in Figures 5-9, identical to 
methods used in previous analyses described in this work. 
In order to automate the process of extracting bout gap-intervals, an algorithm that 
distinguished VF ECG signals from other signals such as asystole, PEA or noise was needed.  In 
collaboration with Dr. David Salcido, an algorithm was developed that uses logistic regression 
based on coefficients derived from a variety of ECG signal characteristics. To validate the 
algorithm, a test set of gaps in the ECG clinical data containing visually confirmed VF (visual 
confirmation being the ‘gold standard’) was used and it was found that the algorithm correctly 
identified the visually confirmed VF segments 98% of the time.  
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3.3.2.2 Models and Results 
Using data obtained from 25,210 bout-gap intervals, univariate linear regression mixed 
models were used for each change in QECG metric (dAMSA, dMS, dCF, dLAC, and dDFA).  The 
results of these models are shown in Table 17 where the coefficient is displayed along with its 
significance p value.   A significance threshold was set to p < .15 and highlighted as yellow. 
The univariate models give evidence that the dQECG responses of dAMSA and dMS 
appear to respond linearly to a larger number of chest compression variables.  The other QECG 
predictors dCF, dLAC, and dDFA did not produce such a robust response to chest compression 
parameter changes over bout-gaps.  The only chest compression parameter that induced a linear 
Table 17: dQECG univariate analysis results (yellow shade p <.15) 
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response in dCF was chest compression duty cycle, while dLAC and dDFA did not respond 
linearly to any chest compression parameter.   
It appears from the univariate logistic models that dMS in response to chest compression 
rate changes may have the most clinically meaningful response.  The coefficient in this model 
informs that for every unit increase in chest compression rate, dMS will increase by 5.15 units.    
The univariate models are limited in their assumption that the dQECG response to any 
chest compression parameter change is linear.  Extreme chest compression values may exhibit a 
parabolic response in dQECG.  To account for this a parabolic mixed effect logistic model was 
then fit to the bout-gap data.  The results of this parabolic model are shown in Table 18.  Chest 
compression rate was tested as this chest compression parameter appeared to be most parabolic in 
nature from past literature by the work of Idris et al.  (Section B in Figure 2).  In this model, neither 
the linear predictor rate, nor the parabolic predictor rate squared, were significantly predictive of 
any dQECG metric. 
Next, to account for the fact that chest compression bouts that take place late in 
resuscitation may have a different response when compared to chest compression bouts that occur 
Table 18: Parabolic mixed model with CC rate as predictor for dQECG 
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in the early part of resuscitation, a time interaction was included in the parabolic mixed model.  
These results are shown in Table 19.  The time interaction was non significant. 
Multivariate models that used chest compression parameters as predictors of dQECG over 
a chest compression bout were then performed using linear mixed models.  After observing that 
dAMSA, dMS, and dCF were the dQECG predictors that primarily responded in the univariate 
models, only these outcome variables were used in the multivariate analysis.  Predictor variables 
that had univariate significance of p < .15 were included as predictors in the initial multivariate 
model.  Age and sex variables were included in each model iteration regardless of predictive 
significance in previous models. 
Table 19: Parabolic mixed model including a time interaction 
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Table 20: Multivariate model prediction of dAMSA and multivariate model prediction of dMS 
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The results of the multivariate model for dAMSA prediction is shown in the left side of 
Table 20.  The chest compression variables that had a significant univariate predictive value were 
CC rate, CC bout length, CC duty cyele dosed, CC CCF, age and sex.  In the first iteration of the 
multivariate dAMSA model,,only CC rate was significant.  After eliminating predictors for the 
second iteration with a cutoff of p < .15, CC bout length was removed from the model due to non-
significance.  
The right side of Table 20 displays the same approach for a multivariate dMS model.  In 
this model only CC rate and CC bout lenght was predictive of dMS in the first and second iterations 
of the model when using a cutoff of p <.15 for the second iteration.  Age and sex predictors were 
left in the model for all iterations. 
Table 21 displays the only multivariate iteration for dCF.  In this model only CC duty cycle 
was significantly predictive of dCF.  Age and sex predictors were left in the model for all iterations. 
Table 21: Multivariate model prediction of dCF
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dLAC and dDFA were not attempted as neither dQECG metric were predictive in the univariate 
analyses 
These multivariate models demonstrate that dAMSA and dMS may be the most robust 
response metrics to changing chest compression parameter values.  They also demonstrate that 
dMS response to CC rate may be the most promising signal to guide an adaptive approach to chest 
compressions. 
To further visualize the relationship between dQECG and chest compression parameters, 
and to address the possibility of an interaction between compression rate and depth, 3D surface 
plots were generated for dAMSA, dMS, and dCF for all chest compression values observed in the 
CCC dataset.  dLAC and dDFA were excluded from this analysis as none of the linear regression 
analysis proved significant for these dQECG metrics. The 3D surface plots are shown in Figure 
38, Figure 39, and Figure 40 respectively.    
The plots demonstrate that there are separate maxima and minima for each dQECG metric. 
dAMSA is maximized at a chest compression depth of 2.0 inches and a chest compression rate of 
107 compressions per minute.  dAMSA is minimized at chest compression depth of 2 inches and 
a chest compression rate 95.2 compressions per minute.   
dMS is maximized at a chest compression depth of 1.1 inches and a chest compression rate 
of 117.5 compressions per minute.  dMS is minimized at a chest compression depth of 1.3 inches 
and a chest compression rate of 97.8 compressions per minute.  
dCF is maximized at a chest compression depth of 1.5 inches and a chest compression rate 
of 91.3 compressions per minute.  dCF is minimized at chest compression depth of 2.5 inches and 
a chest compression rate 96.1 compressions per minute.   
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Figure 38: 3D surface plot of dAMSA, Rate, and Depth 
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Figure 39: 3D surface plot of dMS, Rate and Depth 
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Figure 40: 3D surface plot of dCF, Rate, and Depth 
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The 3D plot assessment shows that there are pronounced peaks and troughs in the 
relationship between dQECG with chest compression rate and chest compression depth. Each 
dQECG metric plotted against the rate and depth chest compression parameters informs us that 
not only do each dQECG metric respond uniquely to changes in chest compression rate and chest 
compression depth, but that there is interaction between chest compression rate and chest 
compression depth.  This phenomenon would complicate usage of multiple dQECG metrics in any 
chest compression feedback algorithm that is developed.  While one dQECG metric could be 
optimized on the 'rate-depth' response surface, another dQECG metric could respond negatively 
for its complement's optimization.  Further work is required to identify not only which dQECG 
metric would take preference in such an optimization scheme, but which metrics could be afforded 
to deteriorate for the optimization of another.  This optimization scheme could have a time 
dependence as well. 
3.3.2.3 Conclusion to clinical data results 
Change in the QECG metric median slope (dAMSA) appeared to be responsive to changes 
in chest compression rates when controlled for all other chest compression parameters, age, and 
sex in the second iteration of the multivariate linear model.  Change in the QECG metric median 
slope (dMS) appeared to be responsive to changes in chest compression rates and dosed chest 
compression depths when controlled for all other chest compression parameters, age, and sex in 
the second iteration of the multivariate linear model.   Change in the dQECG metric median slope 
(dCF) appeared to be responsive to changes in chest compression duty cycle when controlled for 
all other chest compression parameters and age and sex in the first iteration of the multivariate 
model.  The significance cutoff for inclusion in this multivariate model was p < .15.   
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The findings from the dQECG plots suggest that a simple linear regression may not be the 
most optimal way of describing relationships between biosignals such as dQECG and basic chest 
compression parameters such as chest compression rate and chest compression depth.   This was 
observed in the complex nature of the 3D surface plots of dQECG, chest compression rate, and 
chest compression depth.  In these plots there appeared to be an interaction between chest 
compression rate ad chest compression depth.  There were distinct minima and maxima across the 
response of all dQECG responses. 
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4.0  DISCUSSION AND FUTURE DIRECTIONS 
4.1 FEASIBILITY OF ADAPTIVE CPR 
Our initial animal studies showed that a chest compression device can appropriately 
respond to biosignals it receives to tailor chest compressions based on those biosignals.  The initial 
feasibility study described in Aim 1 demonstrated that an adaptive chest compression device could 
not only be engineered and constructed, but proven to respond to real time biosignals generated by 
an animal model.  Real-time sensing of biosignals in an ambulance setting would therefore be 
feasible and next steps would involve miniaturizing the prototype device as well as establishing 
wireless connections between the chest compression device and the clinical monitor measuring the 
biosignals.  Establishment of such a wireless connection and increasing usability by miniaturizing 
would be essential in translating our prototype to clinical practice.  
Additional animal studies described in this work demonstrated that QECG is a potential 
non-invasive biosignal capable of driving changes in chest compressions.  The QECG metrics MS, 
CF, and LAC showed potential to respond to rate changes in the animal experiments described in 
Aim 1.  Results found in Aim 2 demonstrated that change in some QECG metrics (dQECG) 
responded to chest compression changes such as rate.  These results demonstrate initial feasibility 
and translation to human clinical data from the initial animal results. 
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4.2 WHEN IS CPR MOST EFFECTIVE 
The treatment of cardiac arrest remains a ‘black box’ in terms of providing optimized care 
for patients.  Patients may have different chest sizes, different cardiac arrest etiology, and may 
respond to chest compressions and drug treatment in different ways.  The variable nature of 
patients necessitates an adaptive approach to CPR.   
CPR is most effective when it is done immediately after cardiac and when it is done well. 
The work described in this dissertation adds an additional qualifier to measuring CPR quality; In 
addition to maintaining standards for chest compression rate and depth, chest compressions should 
factor in the patient, and how that patient responds to the chest compressions he or she receives. 
This feedback approach to chest compressions has the potential to improve perfusion during CPR, 
and increase the likelihood of favorable outcomes, because it optimizes care based on the patient. 
Any adaptive approach very much depends on how accurately the adaptive device is able 
to acquire and interpret biosignals, and in turn relate those biosignals to the quality of perfusion 
generated by the CCs.  In a prehospital setting however, it would be required that these biosignals 
are non-invasively measured.  QECG metrics that have been used in the swine studies described 
here are non-invasive, readily available, and are derived from the ECG, which is ubiquitously 
recorded in ambulances for every cardiac arrest patient.  A link could therefore be established 
between existing defibrillator monitors and a biosignal driven CPR device.  
Our findings provide preliminary evidence that a beneficial increase in perfusion may be 
achieved in cardiac arrest patients by linking the delivery of CPR to invasive and non-invasive 
biosignals (especially QECG).  With more optimal CPR given to patients, patient survival 
outcomes could be improved.  While we have focused on using biosignals to modify the chest 
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compressions provided by a mechanical CPR device, this feedback could also be given verbally to 
EMS personnel providing manual compressions. 
4.3 MECHANICAL CHEST COMPRESSION DEVICES 
The work conducted here shows preliminary evidence that a feedback based approach to 
CPR may provide better outcomes for cardiac arrest patients.  But even with strong evidence that 
this approach is effective, its eventual adoption by the EMS community is dependent on the wide 
use of mechanical chest compression devices.  It may be possible to give audio biosignal feedback 
to a human provider, for example a device could signal the provider to press deeper and/or faster 
in response to a suboptimal QECG metric the EMS monitor is measuring, but mechanical devices 
have the precision to adjust chest compressions in a much more nuanced and finite way when 
compared to a human provider. 
4.4 CHEST COMPRESSION GUIDANCE 
The studies presented in this work sought to elucidate how to best deliver adaptive chest 
compressions based on biosignals received from a patient.  The primary gaps in knowledge 
discussed in the beginning of this dissertation were characterized by three questions.  These 
questions involved which biosignals to measure, which chest compression parameters to adjust, 
and how much and when to adjust the chest compression parameter.   
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These questions that surround the development of a biosignal driven chest compression 
algorithm include many variables.  Potential biosignal variables taken into consideration for the 
feedback algorithm included invasive pressure in animal models as well as multiple QECG metrics 
in clinical data.  Chest compression parameter variables taken into consideration for the feedback 
algorithm included variables such as chest compression rate, and chest compression depth, and 
chest compression duty cycle.   Additional variables that applied to the approach of biosignal 
driven chest compressions included the development of threshold values for biosignals used in the 
algorithm as well as the time interval of analysis between chest compression adjustments. 
To answer the first question concerning which biosignal to measure, the work described 
here gives preliminary evidence that some non-invasive QECG signals respond to changing chest 
compression parameters.  During the animal tests described in Aim 1, the QECG metric median 
slope (MS) appeared to be most responsive to changes in chest compression parameters in a 
controlled setting.  In the clinical data discussed in Aim 2, change in MS (dMS) responded linearly 
over bouts of chest compressions to the chest compression parameter predictors rate and dosed 
depth.  
To answer the second question of which chest compression parameter to adjust, contrasting 
results were found in separate experiments described in this work.  In the simulation model of 
cardiac arrest in Aim 1, an adaptive approach to chest compressions was applied to a variant 
population with different chest sizes and anatomy along with a fixed approach to chest 
compressions.  A final cardiac output in the adaptive model was compared to its respective final 
cardiac output in the ‘fixed’ model and it was found that the final settings of chest compression 
parameters in the adaptive model involved only chest compression depth changes.  These initial 
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findings demonstrate the potential utility in relying mostly on depth to influence cardiac output 
and chest compression effectiveness. 
 Cardiac output however is difficult to measure non-invasively in the out-of-hospital 
environment.  Therefore, in the subsequent experiments we relied on QECG signals to guide chest 
compression changes.  After the initial feasibility animal test, we again sought to answer the second 
question posed in the introduction of which chest compression parameter to adjust.  Here we found 
that chest compression rate changes, when applied to similar sized animals and controlled for other 
chest compression parameters, produced the strongest linear response in QECG.   
An explanation for the difference in conclusions between the simulation data showing chest 
compression depth as most relevant and clinical data showing chest compression rate as most 
relevant is unclear.  The simulation data is based on a simplified model of the circulatory system 
and is limited in its relevance to animal and human clinical data.  The simulation data helps us 
guide initial algorithm development, however it is ultimately clinical data that will form the 
evidence to base the chest compression parameter priority in the final algorithm feedback loop.  
After examining the clinical findings, we believe chest compression rate may be the best candidate 
to first adjust in future developed chest compression algorithms. 
To answer the third question posed in the introduction concerning how much to adjust chest 
compressions and when to adjust them, the work described in this dissertation provides precursory 
evidence for this component of adaptive chest compressions, but much remains still to be 
answered.  In the feasibility study, increments of chest compression parameter changes were 
arbitrarily set to clinically relevant increments such as depth adjustments of .5 inches.  The time 
intervals of analysis between each change was also set only based on observations in past studies 
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in our lab that showed thirty seconds may be a reasonable amount of time to wait for biosignal 
response to chest compression changes.  
Future work would involve experiments that varied the amount of change in chest 
compression depth, rate, and duty cycle in separate groups and compared those groups to ‘fixed’ 
chest compression that did not adjust.  Additional experiments would also vary the time interval 
of analysis between adjustments; the time interval of thirty seconds used in the feasibility study 
and the time interval of one minute used in the animal study may not be optimal.   
Future additions to the scope of biosignal driven feedback CPR include the addition of 
medication dosage and timing to the treatment algorithm, synchronization of the chest compression 
device the the QRS complexes of a PEA rhythm., and non-invasive biosignals to supplement 
QECG metrics such as doppler ultrasound detection of a patient's pulse.  These additions are 
actively being explored in the lab. 
4.5 DOSED MEASURES OF CPR 
Multiple metrics were used in this work to describe the process and reaction to chest 
compression during CPR.  Process metrics such as chest compression depth, rate, and duty cycle 
characterize the delivery of chest compressions and reaction metrics such as dQECG describe how 
the quantifiable components of the VF waveform respond and change due to the chest compression 
process.  Dosed metrics of chest compression depth, rate, and duty cycle that incorporated the time 
duration of each chest compression bout were also included in the logistic models developed in 
Aim 2.   QECG metrics including AMSA, MS, CF, LAC, and DFA were used to quantify reactions 
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to chest compressions with the aim that positive reactions reflecting better perfusion would both 
respond to and guide adjusting chest compression. 
Individually these process and reaction metrics were predictive of outcomes in response to 
chest compressions.  In the clinical data described in Aim 2, chest compression rate predicted 
survival and AMSA and MS were the strongest predictors of ROOR.  Change in MS (dMS) across 
chest compression bouts (dMS) also responded linearly to chest compression rate changes 
described in Section 3.3.     
The combination of multiple metrics into one outcome prediction model would be desirable 
in simplifying the characterization of chest compressions as a ‘dose of CPR’.  A quantifiable ‘dose’ 
would weigh both the individual process components of chest compressions and a reactionary 
biosignl response into a metric easily conveyed to medical providers with the purpose of 
optimizing outcomes.  Multivariate models described in this work aim to combine these individual 
predictors to make a superior multi-parameter characterization of chest compression effectiveness. 
However only select multivariate models were successful in combining multiple individual 
predictors.   
In the case of chest compression parameter prediction of dQECG discussed over bouts of 
CPR in Section 3.3.2, only chest compression rate was predictive of dAMSA, only chest 
compression rate and dosed chest compression depth were predictive of dMS, and only chest 
compression duty cycle was predictive of dCF in the final multivariate models using significance 
cutoffs of p <.15.  Thus only dMS yielded a model with more than one significant chest 
compression predictor variable.  From this work dMS appears to be the most viable dQECG 
candidate to be used as a biosignal to drive changes in chest compressions during CPR. 
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Future work would necessarily involve more complex models to factor in both chest 
compression parameters and QECG biosignals above the basic linear and quadratic model fits used 
in the work described in this dissertation. 
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5.0  CONCLUSION 
The findings presented in this study establish a foundation for planned subsequent research 
that will involve incorporating CPR quality metrics into the models identifying associations with 
the way CPR is delivered with both QECG and outcome variables.  Findings from this work have 
the potential to provide real-time CPR feedback to health care providers based on patient 
physiology.   
In our first aim we developed the adaptive chest compression device and tested it in animal 
feasibility studies which demonstrated that it responded appropriately to the biosignals it received. 
Next, in a computational model of adaptive chest compressions, adjustments in chest compression 
depth yielded the largest increase in cardiac output in patients with simulated variable physiology. 
In follow-up animal studies, select QECG measures responded to changes in chest compression 
parameters which demonstrated the initial feasibility of QECG measures as a potential biosignal 
in this model.  We found that the QECG measures of median slope, centroid frequency, and log of 
the absolute correlation responded to changes in chest compression rate in the early phase of chest 
compressions.  We found that in late phases of chest compressions the QECG measure median 
slope responded to chest compression rate changes and the QECG measure AMSA responded to 
chest compression duty cycle changes.   
In our second aim, all QECG metrics that we tested in the clinical data set was predictive 
of shock outcome and chest compression rate along with chest compression bout duration were 
predictive of survival.  However, when controlled for the presenting first rhythm status and 
demographic variables, only chest compression bout duration was predictive of survival.  In 
addition to the predictive value of chest compression parameters and QECG measures, associations 
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were found between varying chest compression parameters averaged across bouts of compressions 
with change in QECG values (dQECG) in the clinical data.  Chest compression rate was found to 
be predictive of the dQECG metric median slope (dMS) and the dQECG metric (dAMSA).  Dosed 
compression rate was found to be predictive of the dQECG metric dMS as well.  dCF responded 
to changes in chest compression duty cycle. These findings provide a foundation for delivering 
adaptive chest compressions with the potential of improving survival outcomes to cardiac arrest. 
These studies help us push the boundaries of optimizing perfusion generated from chest 




Figure 41: Phase 1 AMSA response to CC parameter 
changes (Analysis Approach A) 
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Figure 42: Phase 1 DFA response to CC changes 
 (Analysis Approach A) 
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Figure 43: Phase 1 AMSA response to CC parameter 
changes (Analysis Approach B) 
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Figure 44: Phase 1 MS response to CC parameter 
 changes (Analysis Approach B) 
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Figure 45: Phase 1 CF response to CC parameter 
 changes (Analysis Approach B) 
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Figure 46: Phase 1 LAC response to CC parameter 
changes (Analysis Approach B) 
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Figure 47: Phase 1 DFA response to CC parameter 
changes (Analysis Approach B) 
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Figure 48: Phase 2 CF response to CC  
parameter changes (Analysis Approach A) 
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Figure 49: Phase 2 LAC response to CC  
parameter changes (Analysis Approach A) 
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Figure 50: Phase 2 DFA response to CC  
parameter changes (Analysis Approach A) 
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Figure 51: Phase 2 AMSA response to CC 
 parameter change (Analysis Approach B) 
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Figure 52: Phase 2 MS response to CC  
parameter change (Analysis Approach B) 
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Figure 53: Phase 2 CF response to CC 
parameter change (Analysis Approach B) 
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Figure 54: Phase 2 LAC response to CC 
 parameter changes (Analysis Approach B) 
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Figure 55: Phase 2 DFA response to CC  
parameter changes (Analysis Approach B) 
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